Titre :

Defining explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A systematic review.

Auteur(s) :

Gerard, Erwin [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Quindroit, Paul [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Lemaitre, Madleen [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Robert, Laurine [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
GAUTIER, Sophie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Decaudin, Bertrand [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Vambergue, Anne [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Beuscart, Jean-Baptiste [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Titre de la revue :

PLoS ONE

Nom court de la revue :

PLoS One

Numéro :

17

Pagination :

e0274256

Date de publication :

2022-09-12

ISSN :

1932-6203

Mot(s)-clé(s) en anglais :

Aged
Diabetes Mellitus, Type 2
Humans
Hypoglycemic Agents
Inappropriate Prescribing
Kidney Diseases
Metformin
Sulfonylurea Compounds

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Potentially inappropriate prescriptions (PIPs) of antidiabetic drugs (ADs) (PIPADs) to patients with type 2 diabetes mellitus (T2DM) have been reported in some studies. The detection of PIPs in electronic databases requires ...
Lire la suite >Potentially inappropriate prescriptions (PIPs) of antidiabetic drugs (ADs) (PIPADs) to patients with type 2 diabetes mellitus (T2DM) have been reported in some studies. The detection of PIPs in electronic databases requires the development of explicit definitions. This approach is widely used in geriatrics but has not been extended to PIPADs in diabetes mellitus. The objective of the present literature review was to identify all explicit definitions of PIPADs in patients with T2DM. We performed a systematic review of the literature listed on Medline (via PubMed), Scopus, Web of Science, and, Embase between 2010 and 2021. The query included a combination of three concepts ("T2DM" AND "PIPs" AND "ADs") and featured a total of 86 keywords. Two independent reviewers selected publications, extracted explicit definitions of PIPADs, and then classified the definitions by therapeutic class and organ class. Of the 4,093 screened publications, 39 were included. In all, 171 mentions of PIPADs (corresponding to 56 unique explicit definitions) were identified. More than 50% of the definitions were related to either metformin (34%) or sulfonylureas (29%). More than 75% of the definitions were related to either abnormal renal function (56%) or age (22%). In addition, 20% (n = 35) mentions stated that biguanides were inappropriate in patients with renal dysfunction and 17.5% (n = 30) stated that sulfonylureas were inappropriate above a certain age. The definitions of PIPADs were heterogeneous and had various degrees of precision. Our results showed that researchers focused primarily on the at-risk situations related to biguanide prescriptions in patients with renal dysfunction and the prescription of sulfonylureas to older people. Our systematic review of the literature revealed a lack of consensus on explicit definitions of PIPADs, which were heterogeneous and limited (in most cases) to a small number of drugs and clinical situations.Lire moins >

Langue :

Anglais

Comité de lecture :

Oui

Audience :

Internationale

Établissement(s) :

Université de Lille
CHU Lille

Collections :

• METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Date de dépôt :

2023-04-17T14:31:26Z
2023-04-19T06:59:48Z